---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "M+eeDSf2zTMxdfF8AW5GAZoUEOUsk50QVaCUutiwrAfrKcgFErYKgbjtEc1QSgdc4EsHZ9PCHxs/eAMuiCDbQ5jSiiCvfhSIPnMBjrPg3mD0yWysowL8L7/GVG5nT3NplpNMqY/Yo2MZN7+C3WWhhrAC+8hqTk6eiSsRWk6gBe1Qkrad3UNZhDG9in1N/M6YGUBq6wKNF/Ii/rRnLza85nPNMQolHdUEbOFXW08lVPluxAoK9vzRdQHopKIGiTBJ3iRMDAGOKa2focTl3hU2w4J8CEORFKdKw4TGFtDxK8C4hE0RXgbsf3dehfp3Ybn8FSES6B9NVMpbEsEZ79JnE5JlJ5QBr7Bl/e77Lk52loc=;2sQyPx+a66ZEKtARqIasMg=="
---

